share_log

AI/ML Innovations Inc. Announces Closing of Financing

AI/ML Innovations Inc. Announces Closing of Financing

人工智能/機器學習創新公司宣佈結束融資。
Accesswire ·  07/18 05:00

VICTORIA, BC / ACCESSWIRE / July 17, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that that it has completed its previously announced non-brokered private placement (the "Financing") on July 17, 2024. The Company accepted subscriptions on this final tranche of 10,230,000 units at a price of $0.05 per unit, for gross procees of $511,500. The Company paid finders fees to a qualified finder of $26,477.60 and issued 529,550 broker warrants, which are on the same same terms as the warrants forming part of the Units.

AI/ML創新公司("AI/ML")(CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) 是一家人工智能和機器學習行業的創業公司,於2024年7月17日宣佈已完成此前宣佈的定向增發("Financing")。共發行了10230000個單位的認購,每個單位價格爲0.05美元,共獲得511,500美元的總募集資金。該公司向合格的發現者支付了26,477.6美元的發現者費用,併發行了529,550個認股權證,它們與單位的認股權證具有相同的條款和條件。

Each Unit is comprised of one Common Share and one Warrant which will be exercisable into one (1) Common Share of the Company (each a "Warrant Share"). Each Warrant will have a term of three (3) years and will entitle the holder to purchase one (1) Warrant Share at a price of $0.10 per share following the closing date, subject to the Company's right to accelerate expiry upon 30 days' notice if the shares trade at $0.25 for a for a period of at least 30 consecutive trading days.

每個單位由一個普通股和一個認股權證組成,每個認股權證可以行使爲1股公司的普通股(稱爲"認股權證轉換股份")。每個認股權證的有效期爲三(3)年,並且在封閉日期後,每個認股權證的持有人可以以0.10美元/股的價格購買一(1)股認股權證轉換股份,但公司有權在發出30天通知後加速到期,如果股票價格連續30個交易日至少爲0.25美元。

The Company raised a total of $971,500. A total of 19,430,000 Units and 946,550 broker warrants were issued pursuant to the Financing.

本次定向增發共募集資金971,500美元。共發行了19430000個單位和946,550個認股權證。

Securities issued on this closing are subject to a statutory hold period until November 18, 2024.

本次發行的證券受到法定限售期的限制,限售期至2024年11月18日止。

The Company intends to use net proceeds of the Private Placement for working capital requirements.

該公司打算將私募的淨收益用於營運資金的需求。

For more information about AI/ML Innovations:

執行董事Tim Daniels:

For detailed information please see AI/ML's website or the Company's filed documents at .

有關詳細信息,請參閱AI/ML網站或公司歸檔文件。.

For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.

如需更多信息,請聯繫Blake Fallis,電話:(778)405-0882或電子郵件:info@aiml-innovations.com。

About AI/ML Innovations Inc.

關於人工智能/機器學習創新公司。

AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (70% owned by AIML), Tech2Heal (22% ownership commitment by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".

AI/ML 創新公司重組了其業務方向,專注於利用人工智能(AI),機器學習(ML),雲計算服務商和數字化平台推動變革性的醫療管理解決方案和精度支持的提供流程。通過與Health Gauge(AIML擁有70%股權),Tech2Heal(AIML承諾持有22%股權),AI Rx 公司(AIML擁有70%股權)和其他計劃中的增值投資建立戰略伙伴關係,該公司將繼續利用不斷擴大的成長領域,造福於所有公司的利益相關者。AI/ML股票在加拿大證券交易所的交易代碼爲"AIML",在美國場外交易OBTCQB Venture Market的交易代碼爲"AIMLF",在法蘭克福證券交易所的交易代碼爲"42FB"。

On behalf of the Board of Directors
Tim Daniels, Executive Chairman

代表董事會
AI/ML Innovations Inc.已重新調整其業務運營以利用人工智能(AI)和機器學習(ML)的蓬勃發展,初始投資重點放在利用AI、ML、雲計算和數字平台推動變革性健康管理解決方案和精準支持交付的新興數字健康和健康公司上。通過與健康儀表盤(AIML持有95.2%的所有權)、Tech2Heal(最高持股22%,目前AIML擁有12.44%的所有權)、AI Rx Inc.(AIML持有70%的所有權)和其他計劃中的增值投資進行戰略合作,該公司繼續利用不斷擴大的增長領域,造福於公司的所有利益相關者。AI/ML的股票在加拿大證券交易所上市,代碼爲“AIML”,在OTCQB Venture Market上市,代碼爲“AIMLF”,在Frankfurt Stock Exchange上市,代碼爲“42FB”。

THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION, NOR SHALL THERE BE ANY OFFER, SALE, OR SOLICITATION OF SECURITIES IN ANY STATE IN THE UNITED STATES IN WHICH SUCH OFFER, SALE, OR SOLICITATION WOULD BE UNLAWFUL.

本新聞稿不構成在任何司法管轄區出售或購買任何證券的要約,也不應該有任何在美國任何州出售或購買證券的要約、出售或徵求。

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE)
accepts responsibility for the adequacy or accuracy of this release.

加拿大證券交易所及其監管服務提供商(如該術語所定義的CSE政策)概不負責本發佈的充分性或準確性。
加拿大證券交易所及其監管服務提供商(如該術語所定義的CSE政策)概不負責本發佈的充分性或準確性。

SOURCE: AI/ML Innovations, Inc.

來源:AI/ML創新公司,Inc.


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論